Logo image
Anti-virulence therapeutic approaches for Neisseria gonorrhoeae
Journal article   Open access   Peer reviewed

Anti-virulence therapeutic approaches for Neisseria gonorrhoeae

K.Y.L. Lim, C.A. Mullally, E.C. Haese, E.A. Kibble, N.R. McCluskey, E.C. Mikucki, V.C. Thai, K.A. Stubbs, M. Sarkar-Tyson and C.M. Kahler
Antibiotics, Vol.10(2), Article 103
2021
pdf
Neisseria gonorrhoeae.pdfDownloadView
Published (Version of Record) Open Access
url
Free to Read *No subscription requiredView

Abstract

While antimicrobial resistance (AMR) is seen in both Neisseria gonorrhoeae and Neisseria meningitidis, the former has become resistant to commonly available over-the-counter antibiotic treatments. It is imperative then to develop new therapies that combat current AMR isolates whilst also circumventing the pathways leading to the development of AMR. This review highlights the growing research interest in developing anti-virulence therapies (AVTs) which are directed towards inhibiting virulence factors to prevent infection. By targeting virulence factors that are not essential for gonococcal survival, it is hypothesized that this will impart a smaller selective pressure for the emergence of resistance in the pathogen and in the microbiome, thus avoiding AMR development to the anti-infective. This review summates the current basis of numerous anti-virulence strategies being explored for N. gonorrhoeae.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

28 File views/ downloads
97 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.23 Antibiotics & Antimicrobials
1.23.714 Neisseria/Haemophilus
Web Of Science research areas
Infectious Diseases
Pharmacology & Pharmacy
ESI research areas
Pharmacology & Toxicology
Logo image